BackgroundAntiretroviral treatment (ART) options for young children co-infected with HIV and tuberculosis are limited in resource-poor settings due to limited data on the use of efavirenz (EFV). Using
Program Characteristics and Implementation of Three I’s by HIV-TB service integration status in 47 ART programs treating adults in lower income countries.
Objective To quantify the impact of antiretroviral therapy (ART) on mortality in HIV-positive people during tuberculosis (TB) treatment. Design We conducted a systematic literature review and meta-ana